Skip to main content
Tags: letlow | louisiana | covid | icu | remdesivir

Louisiana Rep.-elect Letlow 'Stable' in ICU With COVID-19

luke letlow stands at a podium and speaks
Luke Letlow, R-La., speaks after signing up to run for Louisiana's 5th Congressional District in Baton Rouge, La.  (AP Photo/Melinda Deslatte, File)

By    |   Wednesday, 23 December 2020 06:16 PM EST

Newly elected Rep. Luke Letlow, R-La., was in stable condition in intensive care with COVID-19, a spokesperson said Wednesday.

Letlow was hospitalized Saturday before being transferred to an ICU unit at Ochsner LSU Health in Shreveport, La., spokesman Andrew Bautsch posted on Letlow's Twitter account.

The 41-year-old Letlow was receiving the antiviral medication remdesivir and steroids to help combat the virus, Shreveport Academic Medical Center Chancellor Dr. G.E. Ghali said.

Letlow was admitted to St. Francis Medical Center in Monroe, La., as "a precaution" on Saturday, one day after testing positive. Bautsch added Letlow and his family deeply appreciated the medical care he has received and were "thankful for all of the prayers and support they continue to receive."

Letlow defeated State Rep. Lance Harris, R-Alexandria, in a Dec. 5 runoff to represent Louisiana’s 5th District. He succeeds Republican Ralph Abraham, for whom Letlow was chief of staff. 

President Donald Trump and his personal attorney Rudy Giuliani both received remdesivir after each tested positive for COVID-19. The World Health Organization, however, recommended against the drug as a coronavirus treatment in November due to a lack of evidence that it increases survival rates among patients.

Related Stories

© 2025 Newsmax. All rights reserved.


Politics
Newly elected Rep. Luke Letlow, R-La., was in stable condition in intensive care with COVID-19, a spokesperson said Wednesday.Letlow was hospitalized Saturday before being transferred to an ICU unit at Ochsner LSU Health in Shreveport, La.,...
letlow, louisiana, covid, icu, remdesivir
218
2020-16-23
Wednesday, 23 December 2020 06:16 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved